An observational study in Hyperthyroidism, Osteoporosis and Osteoporosis Risk, sponsored by Uskudar State Hospital. Not yet recruiting. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-05-23.
Sponsored by Uskudar State Hospital · Observational
Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Multiple sclerosis patients are at increased risk for developing osteoporosis. Identifying whether multiple sclerosis patients have information and awareness about this disease is crucial. This study is aimed to investigate awareness and knowledge of osteoporosis in patients with hyperthyroidism.
Osteoporosis is a common disease of bone loss. The reduced bone strength predisposes an increased risk for fractures in older individuals. It can affect people from different ethnicity. Many factors increase the risk of osteoporosis, including age, postmenopausal state, glucocorticoid use, low body weight calcium, vitamin D, immobility, and chronic inflammation. Patients with hyperthyroidism are at high risk of developing osteoporosis due to chronic inflammation and their medications. Patients' knowledge and awareness about osteoporosis are essential for early detection, implementation of lifestyle changes, and treatment compliance. This study aimed to investigate osteoporosis awareness and knowledge about osteoporosis in patients with multiple sclerosis.
112 studies on the registry are indexed under Hyperthyroidism; 27 are open to participants now.
This study's planned enrollment of 400 is above the median of 98 across 48 observational studies indexed under Hyperthyroidism.
Browse Hyperthyroidism studies →Uskudar State Hospital is the lead sponsor of 28 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients aged 18 to 90 years with a diagnosis of hyperthyroidism who gave consent to participate in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients diagnosed with hyperthyroidism.
Other: Patient Participation Form
A form that consists of revised osteoporosis knowledge test, osteoporosis self-efficacy scale, and osteoporosis health belief scale.
Revised Osteoporosis Knowledge Test
The 32-item Revised Osteoporosis Knowledge Test (ROKT; 2012), as reported by Gendler et al. (2015), is a revision of the original 24-item OKT developed by Kim, Horan, \& Gendler (1991). This measure was developed to assess the osteoporosis knowledge of adults. Changes were made to update the original OKT to include current recommendations for calcium and vitamin D, exercise requirements, diagnosis and treatment, and a more comprehensive understanding of bone development and osteoporosis risk factors. It contains two subscales (Nutrition and Exercise), which share 14 common items including risk factors and general knowledge. Although the responses offered to participants are multiple choice (e.g., for risk items: more likely, less likely, neutral, don't know), there is only one correct answer for each item. Responses are dichotomously recoded as correct or incorrect.
Time frame: 1 day
Osteoporosis Self-Efficacy Scale
The Osteoporosis Self-Efficacy Scale (OSES) utilizes perceived susceptibility and seriousness, perceived barriers and benefits, health motivation, and self-confidence in one's ability to take actions needed to prevent osteoporosis to predict possible occurrence of health behaviors.
Time frame: 1 day
Osteoporosis Health Belief Scale
The Osteoporosis Health Belief Scale (OHBS) is a 42-item questionnaire designed to assess susceptibility, seriousness, calcium benefits, calcium barriers, exercise benefits, exercise barriers, and health motivation related to osteoporosis.
Time frame: 1 day
No study locations are listed for this record.
Plan to share: Undecided — Individual participant data will be shared by the corresponding author upon reasonable request.
No publications or documents are linked to this record.
Start is estimated for Aug 2023; primary completion for Dec 2023, 4 months later.
Of 20 observational studies under Hyperthyroidism, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 4 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uskudar State Hospital